SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-005904
Filing Date
2024-02-28
Accepted
2024-02-28 16:29:21
Documents
16
Period of Report
2024-02-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240228_8k.htm   iXBRL 8-K 35364
2 EXHIBIT 3.1 ex_632349.htm EX-3.1 134051
  Complete submission text file 0001437749-24-005904.txt   337585

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240222.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240222_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240222_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240222_pre.xml EX-101.PRE 12019
17 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240228_8k_htm.xml XML 2958
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 24695916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)